Anitoa Systems develops portable molecular diagnostic systems and biosensors for detecting infectious diseases, particularly in resource-limited settings. The company manufactures qPCR instruments and nucleic acid test kits for diseases including COVID-19, dengue, malaria, and monkeypox, enabling rapid point-of-care diagnostics.